Through this conference, we are creating a multidisciplinary cancer prevention research community that sparks new collaborations to enable advances in future cancer prevention approaches. Attendees access insights across the research continuum, from discovery biology through to population and implementation sciences.
This is a must-attend event for researchers from discovery biology, translational and behavioural science, population and implementation research, including established and early-career researchers from across the world.
Register your interestInterested in sponsoring the 2026 edition of our Cancer Prevention Research Conference? Contact us for a confidential discussion.
Email the research events teamOur 2025 event was co-chaired by Sarah Blagden (University of Oxford), Marc Gunter (Imperial College London), and Elizabeth Jaffee (Johns Hopkins University School of Medicine).
View the 2025 programme(PDF, 126 KB)
At Moderna, their mission is to deliver the greatest possible impact to people through mRNA medicines. Since 2010 they have been pioneering the potential of mRNA to develop therapeutics and vaccines for infectious disease, immuno-oncology, rare diseases, cardiovascular disease and autoimmune diseases.
Our 2024 event was co-chaired by John Burn (Newcastle University), Tim Rebbeck (Dana-Farber/Harvard Cancer Center) and Thea Tlsty (University of California, San Francisco).
View the 2024 programme(PDF, 186 KB)
Our research events are designed to showcase cutting-edge science, bring together an international scientific community and facilitate collaborations.
We've prioritised embedding equality, diversity and inclusion, health and safety, patient and public involvement and environmental sustainability across all our research activities.
Our bi-monthly newsletter includes exciting opportunities in prevention and population research, including research stories, funding initiatives and upcoming events.
Explore our latest articles and podcasts for researchers, exploring issues in cancer science and how that science shapes our understanding of the disease.
